The pharmaceutical-sales field, often called "recession-proof," is popular because it offers excellent salary potential, great benefits, flexibility, opportunity for growth, and frequently the use of ...

Hospitals account for about 30% of the $4.5 trillion the U.S. spends annually on healthcare, compared with 9% for drugs. While pharmaceutical companies and insurers often take political heat, ...

BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its target price increased by Bank of America from $42.00 to $45.00 in a ...

and active pharmaceutical ingredients (API). In Q2FY25, consolidated revenue rose 8.0% YoY to Rs. 7,796cr, driven by strong base product sales in the U.S., continued growth trajectory in Europe, and ...

JMP Securities lowered the firm’s price target on Hookipa Pharma (HOOK) to $7 from $24 and keeps an Outperform rating on the shares. Hookipa announced Wednesday that it will reduce its workforce ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has received a consensus recommendation of “Moderate Buy ...

Canaccord raised the firm’s price target on Verona Pharma (VRNA) to $44 from $37 and keeps a Buy rating on the shares. The firm said they reported Q3 results and noted Ohtuvayre initial sales beat ...